MedPage Today on MSN
Novel Rapid-Acting Drug Proves Effective in Severe PTSD
Results support the neuroplastogen as a "potential acute, intermittent" therapy, researche ...
Germany: A recent phase 3 randomized, placebo-controlled trial published in Nature Medicine in September 2025 reports that a ...
Under a new rule, the Department of Veterans Affairs will lower veterans’ disability pay if medication improves their ...
Collins initially took to X to defend the rule, calling criticism “fake news” and stating the policy “simply formalizes VA’s ...
Department of Veterans Affairs published an interim final rule that changes one deceptively simple question at the heart of ...
VA is proposing major changes to disability ratings for sleep apnea, tinnitus, and mental health, shifting away from device based formulas and toward functional impairment.
USA: The investigational neuroplastogen TSND-201 demonstrated significant efficacy in patients with severe post-traumatic stress disorder (PTSD) in a randomized phase II trial. A ...
Shareholder/Analyst Call February 17, 2026 7:30 PM ESTCompany ParticipantsPatrick Redmond O'SullivanEdward Chung - CEO, ...
President Donald Trump’s net approval rating reached a record low of -12 in Morning Consult’s weekly survey, while the share of respondents who said his administration is focused on cost-of-living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results